View ValuationDo-Fluoride New Materials 향후 성장Future 기준 점검 4/6Do-Fluoride New Materials (는) 각각 연간 22.6% 및 21.6% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 22.9% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 10.9% 로 예상됩니다.핵심 정보22.6%이익 성장률22.87%EPS 성장률Chemicals 이익 성장30.6%매출 성장률21.6%향후 자기자본이익률10.86%애널리스트 커버리지Low마지막 업데이트26 Apr 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Pingjiao Yu was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Apr 16Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China공시 • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026공시 • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2025 Results on Apr 16, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2025 results on Apr 16, 2026공시 • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2025 Results on Oct 23, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2025 results on Oct 23, 2025공시 • Jul 02Do-Fluoride New Materials Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025공시 • Apr 25Do-Fluoride New Materials Co., Ltd. Proposes Final Cash Distribution for 2024Do-Fluoride New Materials Co., Ltd. announced on 24 April 2025 the final profit distribution proposal for 2024 as follows: Cash dividend/10 shares (tax included): CNY 2.00000000.공시 • Apr 24Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China공시 • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025공시 • Jan 23Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million.Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million on January 21, 2025. A cash consideration of CNY 28.46 million will be paid by Do-Fluoride New Materials Co., Ltd. As part of consideration, CNY 28.46 million is paid towards common equity of Henan Yifeng Electronic New Materials Co., Ltd. The transaction will be financed through equity investment of CNY 28.46 million. As of October 31, 2024 Henan Yifeng Electronic New Materials Co., Ltd. reported total assets of CNY 65 million and net assets of CNY 40 million. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board.공시 • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025Reported Earnings • Nov 01Third quarter 2024 earnings released: CN¥0.033 loss per share (vs CN¥0.14 profit in 3Q 2023)Third quarter 2024 results: CN¥0.033 loss per share (down from CN¥0.14 profit in 3Q 2023). Revenue: CN¥2.27b (down 36% from 3Q 2023). Net loss: CN¥45.4m (down 123% from profit in 3Q 2023). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.42, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 70% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.58 per share.공시 • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥11.38, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 69% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.26 per share.Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.022 (vs CN¥0.15 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.022 (down from CN¥0.15 in 2Q 2023). Revenue: CN¥2.48b (down 11% from 2Q 2023). Net income: CN¥30.8m (down 81% from 2Q 2023). Profit margin: 1.2% (down from 5.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has fallen by 35% per year, which means it is performing significantly worse than earnings.New Risk • Aug 30New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 28% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 112% Paying a dividend despite having no free cash flows. High level of non-cash earnings (28% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (2.8% net profit margin). Shareholders have been diluted in the past year (11% increase in shares outstanding).Buy Or Sell Opportunity • Aug 27Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 29% to CN¥9.48. The fair value is estimated to be CN¥12.10, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 66% in 2 years. Earnings are forecast to grow by 217% in the next 2 years.공시 • Jun 29Do-Fluoride New Materials Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024Valuation Update With 7 Day Price Move • Apr 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥13.39, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 7.8% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.60 per share.공시 • Mar 30Do-Fluoride New Materials Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024공시 • Mar 29Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan ChinaReported Earnings • Mar 29Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥1.81 in FY 2022)Full year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥509.8m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Reported Earnings • Feb 29Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥1.81 in FY 2022)Full year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥508.6m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥10.50, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 33% over the past three years.공시 • Dec 30Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2023 results on Mar 29, 2024Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.31 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.31 in 3Q 2022). Revenue: CN¥3.52b (up 7.7% from 3Q 2022). Net income: CN¥194.4m (down 41% from 3Q 2022). Profit margin: 5.5% (down from 10.0% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.New Risk • Aug 31New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (7.0% net profit margin). Shareholders have been diluted in the past year (11% increase in shares outstanding).Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.63 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.63 in 2Q 2022). Revenue: CN¥2.79b (down 17% from 2Q 2022). Net income: CN¥158.5m (down 76% from 2Q 2022). Profit margin: 5.7% (down from 20% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 23Full year 2022 earnings released: EPS: CN¥2.54 (vs CN¥1.73 in FY 2021)Full year 2022 results: EPS: CN¥2.54 (up from CN¥1.73 in FY 2021). Revenue: CN¥12.4b (up 58% from FY 2021). Net income: CN¥1.95b (up 55% from FY 2021). Profit margin: 16% (in line with FY 2021). Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth.Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. Independent Director Chunyan Li was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Valuation Update With 7 Day Price Move • Nov 29Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥38.22, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 230% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥50.93 per share.Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.57 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.43 (down from CN¥0.57 in 3Q 2021). Revenue: CN¥3.27b (up 36% from 3Q 2021). Net income: CN¥326.6m (down 24% from 3Q 2021). Profit margin: 10.0% (down from 18% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 11Second quarter 2022 earnings released: EPS: CN¥0.88 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.88 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥3.37b (up 102% from 2Q 2021). Net income: CN¥670.6m (up 212% from 2Q 2021). Profit margin: 20% (up from 13% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 33%, compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥47.51, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 247% over the past three years.Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥39.15, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 242% over the past three years.Buying Opportunity • Apr 29Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 26%. The fair value is estimated to be CN¥38.13, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 108%. Revenue is forecast to grow by 63% in 2 years. Earnings is forecast to grow by 3.5% in the next 2 years.Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥42.16, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 176% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥38.76 per share.Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥1.73 (up from CN¥0.07 in FY 2020). Revenue: CN¥7.81b (up 84% from FY 2020). Net income: CN¥1.26b (up CN¥1.21b from FY 2020). Profit margin: 16% (up from 1.1% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 14%. Over the next year, revenue is forecast to grow 30%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.Reported Earnings • Oct 16Third quarter 2021 earnings released: EPS CN¥0.57 (vs CN¥0.003 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.40b (up 111% from 3Q 2020). Net income: CN¥429.4m (up CN¥431.5m from 3Q 2020). Profit margin: 18% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Aug 27Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.021 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.67b (up 81% from 2Q 2020). Net income: CN¥214.7m (up CN¥200.2m from 2Q 2020). Profit margin: 13% (up from 1.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 63% per year, which means it is well ahead of earnings.Reported Earnings • Apr 26Full year 2020 earnings released: EPS CN¥0.071 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 116 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 08Full year 2020 earnings released: EPS CN¥0.07 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 110 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Jan 18New 90-day high: CN¥21.23The company is up 33% from its price of CN¥15.95 on 21 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Is New 90 Day High Low • Dec 25New 90-day high: CN¥20.31The company is up 66% from its price of CN¥12.24 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.Is New 90 Day High Low • Dec 09New 90-day high: CN¥17.26The company is up 57% from its price of CN¥10.98 on 10 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.Is New 90 Day High Low • Nov 10New 90-day high: CN¥16.90The company is up 49% from its price of CN¥11.37 on 12 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.89 per share.Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total losses of CN¥504.7m, with losses widening by CN¥499.6m from the prior year. Total revenue was CN¥3.74b over the last 12 months, down 13% from the prior year.Is New 90 Day High Low • Oct 10New 90-day high: CN¥13.80The company is up 16% from its price of CN¥11.92 on 10 July 2020. The Chinese market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.44 per share.Is New 90 Day High Low • Sep 18New 90-day high: CN¥13.32The company is up 21% from its price of CN¥11.00 on 19 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.34 per share.이익 및 매출 성장 예측XSEC:002407 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202820,5921,234N/AN/A112/31/202719,6951,151N/AN/A112/31/202615,7731,096N/AN/A13/31/202610,552524-1,162-278N/A12/31/20259,434213-858199N/A9/30/20258,017-246-468679N/A6/30/20257,899-319-689573N/A3/31/20258,204-282-1,022129N/A12/31/20248,249-308-1,334-313N/A9/30/202410,07164-1,834-881N/A6/30/202411,309304-2,446-1,604N/A3/31/202411,609440-1,461-252N/A12/31/202311,938511-1,183330N/A9/30/202311,848681-7081,152N/A6/30/202311,596814-422,128N/A3/31/202312,1761,326-1,1351,219N/A1/1/202312,3581,948-8211,753N/A9/30/202211,7882,252-2772,213N/A6/30/202210,9212,3552282,506N/A3/31/20229,2161,8995852,354N/A12/31/20217,8091,2607581,975N/A9/30/20216,671772-6892N/A6/30/20215,409341-624-9N/A3/31/20214,661141-43340N/A12/31/20204,24549-440-37N/A9/30/20203,829-49970270N/A6/30/20203,717-483212455N/A3/31/20203,919-454-135147N/A12/31/20193,998-411N/A45N/A9/30/20194,3110N/A73N/A6/30/20194,26423N/A321N/A3/31/20193,99334N/A431N/A12/31/20183,94566N/A428N/A9/30/20183,962217N/A153N/A6/30/20183,940237N/A-181N/A3/31/20183,952264N/A10N/A12/31/20173,768257N/A28N/A9/30/20173,250307N/A44N/A6/30/20173,133378N/A248N/A3/31/20173,007435N/A128N/A12/31/20162,871478N/A61N/A9/30/20162,843389N/A30N/A6/30/20162,484280N/A-75N/A3/31/20162,276143N/A-115N/A12/31/20152,19739N/A78N/A9/30/20152,12137N/A-115N/A6/30/20152,24524N/A11N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 002407 의 연간 예상 수익 증가율(22.6%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 002407 의 연간 수익(22.6%)이 CN 시장(27.2%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 002407 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 002407 의 수익(연간 21.6%)이 CN 시장(연간 16.2%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 002407 의 수익(연간 21.6%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 002407의 자본 수익률은 3년 후 10.9%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 16:56종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Do-Fluoride New Materials Co., Ltd.는 4명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Zhe WangCitic Securities Co., Ltd.Dongying WuCitigroup IncJack LuMorgan Stanley1명의 분석가 더 보기
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Pingjiao Yu was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Apr 16Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 07, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
공시 • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026
공시 • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2025 Results on Apr 16, 2026Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2025 results on Apr 16, 2026
공시 • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2025 Results on Oct 23, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2025 results on Oct 23, 2025
공시 • Jul 02Do-Fluoride New Materials Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025
공시 • Apr 25Do-Fluoride New Materials Co., Ltd. Proposes Final Cash Distribution for 2024Do-Fluoride New Materials Co., Ltd. announced on 24 April 2025 the final profit distribution proposal for 2024 as follows: Cash dividend/10 shares (tax included): CNY 2.00000000.
공시 • Apr 24Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025Do-Fluoride New Materials Co., Ltd., Annual General Meeting, May 15, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
공시 • Mar 31Do-Fluoride New Materials Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025
공시 • Jan 23Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million.Do-Fluoride New Materials Co., Ltd. (SZSE:002407) agreed to acquire 54% stake in Henan Yifeng Electronic New Materials Co., Ltd. from DFD Group Co., Ltd. for CNY 28.5 million on January 21, 2025. A cash consideration of CNY 28.46 million will be paid by Do-Fluoride New Materials Co., Ltd. As part of consideration, CNY 28.46 million is paid towards common equity of Henan Yifeng Electronic New Materials Co., Ltd. The transaction will be financed through equity investment of CNY 28.46 million. As of October 31, 2024 Henan Yifeng Electronic New Materials Co., Ltd. reported total assets of CNY 65 million and net assets of CNY 40 million. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board.
공시 • Dec 31Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025
Reported Earnings • Nov 01Third quarter 2024 earnings released: CN¥0.033 loss per share (vs CN¥0.14 profit in 3Q 2023)Third quarter 2024 results: CN¥0.033 loss per share (down from CN¥0.14 profit in 3Q 2023). Revenue: CN¥2.27b (down 36% from 3Q 2023). Net loss: CN¥45.4m (down 123% from profit in 3Q 2023). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.42, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 70% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥4.58 per share.
공시 • Sep 30Do-Fluoride New Materials Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥11.38, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 69% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.26 per share.
Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.022 (vs CN¥0.15 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.022 (down from CN¥0.15 in 2Q 2023). Revenue: CN¥2.48b (down 11% from 2Q 2023). Net income: CN¥30.8m (down 81% from 2Q 2023). Profit margin: 1.2% (down from 5.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has fallen by 35% per year, which means it is performing significantly worse than earnings.
New Risk • Aug 30New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 28% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 112% Paying a dividend despite having no free cash flows. High level of non-cash earnings (28% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (2.8% net profit margin). Shareholders have been diluted in the past year (11% increase in shares outstanding).
Buy Or Sell Opportunity • Aug 27Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 29% to CN¥9.48. The fair value is estimated to be CN¥12.10, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 66% in 2 years. Earnings are forecast to grow by 217% in the next 2 years.
공시 • Jun 29Do-Fluoride New Materials Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024
Valuation Update With 7 Day Price Move • Apr 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥13.39, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 7.8% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.60 per share.
공시 • Mar 30Do-Fluoride New Materials Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
공시 • Mar 29Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024Do-Fluoride New Materials Co., Ltd., Annual General Meeting, Apr 18, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China
Reported Earnings • Mar 29Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥1.81 in FY 2022)Full year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥509.8m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Reported Earnings • Feb 29Full year 2023 earnings released: EPS: CN¥0.46 (vs CN¥1.81 in FY 2022)Full year 2023 results: EPS: CN¥0.46 (down from CN¥1.81 in FY 2022). Revenue: CN¥11.9b (down 3.4% from FY 2022). Net income: CN¥508.6m (down 74% from FY 2022). Profit margin: 4.3% (down from 16% in FY 2022). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥10.50, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 33% over the past three years.
공시 • Dec 30Do-Fluoride New Materials Co., Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024Do-Fluoride New Materials Co., Ltd. announced that they will report fiscal year 2023 results on Mar 29, 2024
Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.31 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.31 in 3Q 2022). Revenue: CN¥3.52b (up 7.7% from 3Q 2022). Net income: CN¥194.4m (down 41% from 3Q 2022). Profit margin: 5.5% (down from 10.0% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
New Risk • Aug 31New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (7.0% net profit margin). Shareholders have been diluted in the past year (11% increase in shares outstanding).
Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.63 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.63 in 2Q 2022). Revenue: CN¥2.79b (down 17% from 2Q 2022). Net income: CN¥158.5m (down 76% from 2Q 2022). Profit margin: 5.7% (down from 20% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 23Full year 2022 earnings released: EPS: CN¥2.54 (vs CN¥1.73 in FY 2021)Full year 2022 results: EPS: CN¥2.54 (up from CN¥1.73 in FY 2021). Revenue: CN¥12.4b (up 58% from FY 2021). Net income: CN¥1.95b (up 55% from FY 2021). Profit margin: 16% (in line with FY 2021). Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has only increased by 44% per year, which means it is significantly lagging earnings growth.
Board Change • Feb 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. Independent Director Chunyan Li was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Nov 29Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥38.22, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 230% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥50.93 per share.
Reported Earnings • Oct 29Third quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.57 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.43 (down from CN¥0.57 in 3Q 2021). Revenue: CN¥3.27b (up 36% from 3Q 2021). Net income: CN¥326.6m (down 24% from 3Q 2021). Profit margin: 10.0% (down from 18% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 11Second quarter 2022 earnings released: EPS: CN¥0.88 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.88 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥3.37b (up 102% from 2Q 2021). Net income: CN¥670.6m (up 212% from 2Q 2021). Profit margin: 20% (up from 13% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 33%, compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥47.51, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 247% over the past three years.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥39.15, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 242% over the past three years.
Buying Opportunity • Apr 29Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 26%. The fair value is estimated to be CN¥38.13, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 108%. Revenue is forecast to grow by 63% in 2 years. Earnings is forecast to grow by 3.5% in the next 2 years.
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥42.16, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 176% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥38.76 per share.
Reported Earnings • Mar 11Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: CN¥1.73 (up from CN¥0.07 in FY 2020). Revenue: CN¥7.81b (up 84% from FY 2020). Net income: CN¥1.26b (up CN¥1.21b from FY 2020). Profit margin: 16% (up from 1.1% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 14%. Over the next year, revenue is forecast to grow 30%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Oct 16Third quarter 2021 earnings released: EPS CN¥0.57 (vs CN¥0.003 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥2.40b (up 111% from 3Q 2020). Net income: CN¥429.4m (up CN¥431.5m from 3Q 2020). Profit margin: 18% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Aug 27Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.021 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.67b (up 81% from 2Q 2020). Net income: CN¥214.7m (up CN¥200.2m from 2Q 2020). Profit margin: 13% (up from 1.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has increased by 63% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 26Full year 2020 earnings released: EPS CN¥0.071 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 116 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 08Full year 2020 earnings released: EPS CN¥0.07 (vs CN¥0.61 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.25b (up 9.2% from FY 2019). Net income: CN¥48.6m (up CN¥464.9m from FY 2019). Profit margin: 1.1% (up from net loss in FY 2019). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 110 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Jan 18New 90-day high: CN¥21.23The company is up 33% from its price of CN¥15.95 on 21 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Is New 90 Day High Low • Dec 25New 90-day high: CN¥20.31The company is up 66% from its price of CN¥12.24 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Dec 09New 90-day high: CN¥17.26The company is up 57% from its price of CN¥10.98 on 10 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Nov 10New 90-day high: CN¥16.90The company is up 49% from its price of CN¥11.37 on 12 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.89 per share.
Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total losses of CN¥504.7m, with losses widening by CN¥499.6m from the prior year. Total revenue was CN¥3.74b over the last 12 months, down 13% from the prior year.
Is New 90 Day High Low • Oct 10New 90-day high: CN¥13.80The company is up 16% from its price of CN¥11.92 on 10 July 2020. The Chinese market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.44 per share.
Is New 90 Day High Low • Sep 18New 90-day high: CN¥13.32The company is up 21% from its price of CN¥11.00 on 19 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.34 per share.